|
|
|
Cell Culture: The Market for Media, Sera and Reagents, 5th Edition
4/24/2013 | published by: Kalorama Information
Cell Culture: The Market for Media, Sera and Reagents -
The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Cell culture techniques have been used
|
read more...
|
$3,995.00
|
|
Pulmonary Tuberculosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Pulmonary Tuberculosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Tuberculosis,
|
read more...
|
$2,000.00
|
|
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Muscle Atrophy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Muscle Atrophy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Atrophy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Muscle Atrophy,
|
read more...
|
$2,000.00
|
|
Metastatic Ovarian Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Influenza B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Influenza B Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Influenza B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic
|
read more...
|
$2,000.00
|
|
Primary Systemic Amyloidosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Primary Systemic Amyloidosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
read more...
|
$2,000.00
|
|
Vitiligo – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Vitiligo – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Vitiligo - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vitiligo, complete with latest
|
read more...
|
$2,000.00
|
|
Cardiac Fibrosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Cardiac Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiac Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cardiac Fibrosis,
|
read more...
|
$2,000.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports